|
|||
|
Multiple Sclerosis Information
Search
This Month
Favorite Links
Month Archive
|
Sunday, July 5
by
All About MS
on Sun 05 Jul 2009 11:02 AM CST
Teva Pharmaceutical Industries Ltd. and Active Biotech today announced completion of patient enrollment for the second pivotal Phase III clinical trial, BRAVO, evaluating the novel, oral once-daily immunomodulating more »
|
||